» Articles » PMID: 26883082

HIV Coreceptor Tropism Determination and Mutational Pattern Identification

Overview
Journal Sci Rep
Specialty Science
Date 2016 Feb 18
PMID 26883082
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

In the early stages of infection, Human Immunodeficiency Virus Type 1 (HIV-1) generally selects CCR5 as the primary coreceptor for entering the host cell. As infection progresses, the virus evolves and may exhibit a coreceptor-switch to CXCR4. Accurate determination coreceptor usage and identification key mutational patterns associated tropism switch are essential for selection of appropriate therapies and understanding mechanism of coreceptor change. We developed a classifier composed of two coreceptor-specific weight matrices (CMs) based on a full-scale dataset. For this classifier, we found an AUC of 0.97, an accuracy of 95.21% and an MCC of 0.885 (sensitivity 92.92%; specificity 95.54%) in a ten-fold cross-validation, outperforming all other methods on an independent dataset (13% higher MCC value than geno2pheno and 15% higher MCC value than PSSM). A web server (http://spg.med.tsinghua.edu.cn/CM.html) based on our classifier was provided. Patterns of genetic mutations that occur along with coreceptor transitions were further identified based on the score of each sequence. Six pairs of one-AA mutational patterns and three pairs of two-AA mutational patterns were identified to associate with increasing propensity for X4 tropism. These mutational patterns offered new insights into the mechanism of coreceptor switch and aided in monitoring coreceptor switch.

Citing Articles

HIV-1 exploits LBPA-dependent intraepithelial trafficking for productive infection of human intestinal mucosa.

Rader A, Cloherty A, Patel K, Almandawi D, Pajkrt D, Wolthers K PLoS Pathog. 2024; 20(12):e1012714.

PMID: 39729509 PMC: 11676502. DOI: 10.1371/journal.ppat.1012714.


Phylogenetic signatures reveal multilevel selection and fitness costs in SARS-CoV-2.

Bonetti Franceschi V, Volz E Wellcome Open Res. 2024; 9:85.

PMID: 39132669 PMC: 11316176. DOI: 10.12688/wellcomeopenres.20704.2.


Distinct genetic clusters in HIV-1 CRF01_AE-infected patients induced variable degrees of CD4 T-cell loss.

Li K, Chen H, Li J, Feng Y, Liang S, Rashid A mBio. 2024; 15(3):e0334923.

PMID: 38385695 PMC: 10936439. DOI: 10.1128/mbio.03349-23.


SHIV-C109p5 NHP induces rapid disease progression in elderly macaques with extensive GI viral replication.

Bose D, Deb Adhikary N, Xiao P, Rogers K, Ferrell D, Cheng-Mayer C J Virol. 2024; 98(2):e0165223.

PMID: 38299866 PMC: 10878093. DOI: 10.1128/jvi.01652-23.


The Effect of Treatment-Associated Mutations on HIV Replication and Transmission Cycles.

Johnson M, Jones C, Clark D Viruses. 2023; 15(1).

PMID: 36680147 PMC: 9861436. DOI: 10.3390/v15010107.


References
1.
Ivanoff L, Dubay J, Morris J, Roberts S, Gutshall L, Sternberg E . V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity. Virology. 1992; 187(2):423-32. DOI: 10.1016/0042-6822(92)90444-t. View

2.
Raymond S, Delobel P, Mavigner M, Cazabat M, Souyris C, Encinas S . Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage. J Clin Virol. 2009; 47(2):126-30. DOI: 10.1016/j.jcv.2009.11.018. View

3.
de Jong J, de Ronde A, Keulen W, Tersmette M, Goudsmit J . Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. J Virol. 1992; 66(11):6777-80. PMC: 240176. DOI: 10.1128/JVI.66.11.6777-6780.1992. View

4.
Trouplin V, Salvatori F, Cappello F, Obry V, Brelot A, Heveker N . Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay. J Virol. 2000; 75(1):251-9. PMC: 113919. DOI: 10.1128/JVI.75.1.251-259.2001. View

5.
Trujillo J, Wang W, Lee T, Essex M . Identification of the envelope V3 loop as a determinant of a CD4-negative neuronal cell tropism for HIV-1. Virology. 1996; 217(2):613-7. DOI: 10.1006/viro.1996.0158. View